Cellosaurus logo
expasy logo

Cellosaurus LD630 (CVCL_EJ18)

[Text version]
Cell line name LD630
Accession CVCL_EJ18
Resource Identification Initiative To cite this cell line use: LD630 (RRID:CVCL_EJ18)
Sequence variations
  • Gene deletion; HGNC; 1787; CDKN2A; Zygosity=Homozygous (PubMed=9850064).
  • Mutation; HGNC; 11998; TP53; Simple; p.Arg280Lys (c.839G>A); ClinVar=VCV000376657; Zygosity=Unspecified (PubMed=9850064).
Disease Bladder carcinoma (NCIt: C4912)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Sex of cell Sex unspecified
Age at sampling Age unspecified
Category Cancer cell line
Publications

PubMed=9850064
Markl I.D.C., Jones P.A.
Presence and location of TP53 mutation determines pattern of CDKN2A/ARF pathway inactivation in bladder cancer.
Cancer Res. 58:5348-5353(1998)

PubMed=29732388; DOI=10.3233/BLC-180167
Zuiverloon T.C.M., de Jong F.C., Costello J.C., Theodorescu D.
Systematic review: characteristics and preclinical uses of bladder cancer cell lines.
Bladder Cancer 4:169-183(2018)

Cross-references
Cell line databases/resources cancercelllines; CVCL_EJ18
Encyclopedic resources Wikidata; Q54902373
Polymorphism and mutation databases Cosmic; 943741
IARC_TP53; 10282
Entry history
Entry creation26-Sep-2016
Last entry update05-Oct-2023
Version number10